Newfoundlander Tony received a new heart @PMunkCardiacCtr earlier this year. With no #hearttransplant resources in #NL Tony will stay in #ON for the foreseeable future. Back home, his brother Craig awaits the same fate. ?https://t.co/lXd11KHDDW

#CardioTwitter https://t.co/yIkDpKWxxj

Call for abstracts #CardioTwitter Canada⤵️ https://t.co/ijXEugGDrV

#HerHeartMatters #CardioTwitter https://t.co/aZ8F7jGqz8

#CardioTwitter https://t.co/XmZHfUx2T5

?@American_Heart Scientific Statement CVD Risk Factors in Women: Impact of Race & Ethnicity Huge thanks to coauthors @DrJMieres @ggvela @jennlewey @GarimaVSharmaMD @DrRachelMBond @anavasac @GayenellMagwood @DrEugeneYang @rblument1 @RMBTcardioMD Dr. Fretts https://t.co/0yenUw7Eqr https://t.co/f4Q2zgcYxL

Cancer care is characterized by therapeutic urgency Heart failure care is characterized by therapeutic lackadaisicalness Risk similar Benefit Rx >>> HF Benefit Rx earlier HF Tolerability Rx >>HF Safety Rx >>HF Costs Rx <<< HF Value Rx >>>HF @SJGreene_md https://t.co/8UL5gVGHLx

The 5th Annual #HeartFailureWeekCan is fast approaching. Our theme this year is "It's not normal to be breathless." Help us⬆️public knowledge of HF by sharing info & resources during campaign week May 1-7. #CardioTwitter ➡️https://t.co/GxeEIYYRJ0… https://t.co/6K5DjTDohX

Marginalized racial and ethnic groups, women, and other historically disenfranchised populations are substantially underrepresented in clinical trial Why Diverse #ClinicalTrial Participation Matters ? @NEJM https://t.co/1Fqs07FjVO https://t.co/Vd7BHWbUGj

Improving heart failure diagnosis in community settings can prevent hospitalisations and save lives. Read our report to learn about a variety of promising initiatives to diagnose HF early. https://t.co/EldsYzmO34